SWOT analysis, Managerial Strategy, and Tactics

Solution Preview

OK. I hit all the above areas. The only problem is regression. While I am very familiar with the methods, if I don't know the variables, the theory, the hypothesis or the size of the sample, I can only provide theory. what I did was define the major terms and figures that decide whether or not the model (or specific variable) is significant.
See the .doc below and contact me if anything can be expanded or clarified.

DearMary: Thanks for choosing to work with us here. I'm Matt Johnson, and have a Ph.D. In international political economy. Don't worry, struggling with these issues is no big deal. It is smart of you to ask for help when you need it.

I assume here that all the terms you are asking about concern the Walgreen's Corporation, that is, the pharmacy chain.

Overview and History:
This I think you got. The firm was founded by CR Walgreen in 1902. He was a chemist and manufactured his own drugs personally. Within 10 years, it turned into a chain. By 1926, there were 100 stores, and rumor has it, Walgreen's invented the milkshake. They also opened a store inside the Pentagon in 1943, though it was finally closed don in 1986. The firm also invented the child proof container lid. In addition, they are also rumored to have created the first "drive through" pharmacy in 1992, and was the first drugstore to offer products and services online in the late 1990s. The rest you know.

The Market
The competition is intense. In general, this is an oligopolistic market, dominated by the huge chains such as WalMart, Giant, Safeway, Rite Aid, Target and CVS. It is important to know about 50% of pharmacies are located in larger stores like WalMart. Regardless of the competition, Walgreen's still is the #1 pharmacy in the US, with roughly 11,000 pharmacists and about 5500 stores.

Resources:
The most significant development is the recent merger with an HBA firm called Alliance Boots. The supply chain was the main reason for it. Boots had a compact and well run supply system that Walgreen's can now tap into.

In terms of expenses, Walgreen's has substantially cut costs as their income has risen. Even as the number of customers of pharmacies and drug stores has declined, Walgreen's has seen its revenue increase over last year by 2.5% to $5.8 billion. Walgreen's has very little commercial debt, but quite a bit of private debt. It maintains two unsecured sources of financing (that is, something like a credit card, not backed with collateral) for day to day activities. Nevertheless, Moody's rating agency rates their credit worthiness as "negative." It's long term debt is about $3 billion.

On hand, Walgreens's has about $1 billion that is ...